Acquires and holds economic rights to future milestone and royalty payments related to pre-market clinical candidates and marketed therapeutics, in exchange for providing biotechnology companies with access to non-dilutive, non-recourse capital to further the development of their drug candidates or for general corporate purposes. Delaware incorporated